Skip to main content
. 2020 Oct 23;28(9):954–962. doi: 10.5551/jat.59774

Table 1. Patient and limb characteristics.

Patient characteristics ( n = 44) Procedure characteristics ( n = 60)
Sex 32 (73%) Pre dilation 60 (100%)
Age, years 74±8 Scoring balloon 18 (30%)
Current smoking 14 (32%) Non-compliant balloon 27 (45%)
Hypertension 38 (86%) Post dilation 4 (6.7%)
Hyperlipidemia 38 (86%) DCB
Diabetes mellitus 33 (75%) Lutonix 47 (78%)
Renal impairment IN.PACT 13 (22%)
eGFR ≥ 60 ml/min/1.73 m 2 22 (50%) Residual stenosis
eGFR = 30–60 ml/min/1.73 m 2 15 (34%) 0% 2 (3%)
eGFR = 15–30 ml/min/1.73 m 2 1 (2%) 10% 23 (38%)
eGFR<15 ml/min/1.73 m 2 or on dialysis 6 (14%) 20% 14 (23%)
Aspirin use 44 (100%) 30% 15 (25%)
P2Y12 inhibitor use 43 (98%) 40% 4 (7%)
Anticoagulant use 10 (23%) 50% 2 (3%)
Statin use 30 (68%) Angiographic dissection
Limb characteristics ( n = 60) None 4 (7%)
Rutherford classification A 11 (18%)
Category 2 30 (50%) B 16 (27%)
Category 3 17 (28%) C 23 (38%)
Category 4 3 (5%) D 6 (10%)
Category 5 7 (12%) IVUS-evaluated post -procedural minimal lumen area (mm 2 ) 12.6±4.4
Category 6 3 (5%)
Ankle brachial index 0.76±0.20
(missing data) 1 (2%)
Lesion characteristics ( n = 60)
Reference vessel diameter (mm) 4.8±0.8
(missing data) 1 (2%)
Chronic total occlusion 7 (12%)
Lesion length (mm) 127±78
PACSS classification
Grade 0 37 (62%)
Grade 1 4 (7%)
Grade 2 7 (12%)
Grade 3 3 (5%)
Grade 4 9 (15%)
TASC II classification
Class A 19 (32%)
Class B 13 (22%)
Class C 9 (15%)
Class D 19 (32%)
Below-the-knee runoff
1 runoff 27 (45%)
2 runoffs 27 (45%)
3 runoffs 6 (10%)

eGFR, estimated glomerular filtration rate; P2Y12, platelet adenosine diphosphate receptor; PACSS, peripheral artery calcification scoring system; TASC, Trans-Atlantic Inter-Society Consensus; DCB, drug-eluting balloon; IVUS, intravascular ultrasound.

Data are expressed as the mean±standard deviation or number (percentage).